K Number
K152786
Device Name
A Plus Internal Fixture System
Date Cleared
2016-06-07

(256 days)

Product Code
Regulation Number
872.3640
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The A Plus Internal Fixture System is intended to be placed in the upper or lower jaw to support prosthetic devices, such as artificial teeth, and to restore a patient's chewing function. This may be accomplished using either a two stage surgical procedure or a single stage surgical procedure. It is intended for delayed loading.
Device Description
The A Plus internal fixtures are made with Grade 4 titanium. The systems consist of one-stage and two-stage root form dental implants, associated with abutment systems, which provide the dentist with screw and cement retained restoration options. The devices covered by this submission are A Plus internal fixture, screw, abutment and some accessories. The diameters of A Plus internal fixtures are 3.4 mm, 3.8 mm, 4.3 mm, 4.8 mm, and 5.3 mm, and the lengths are 8 mm, 10 mm, 12 mm, and 14 mm.
More Information

No
The summary describes a mechanical dental implant system and does not mention any software, algorithms, or AI/ML capabilities.

Yes.
The device is intended to restore a patient's chewing function, which is a therapeutic purpose.

No

The device description clearly states its purpose is to support prosthetic devices and restore chewing function, not to diagnose medical conditions or provide diagnostic information.

No

The device description clearly states it is a system of physical components made of Grade 4 titanium, including fixtures, screws, abutments, and accessories, intended for surgical implantation. This is a hardware device, not software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is to be placed in the jaw to support prosthetic devices and restore chewing function. This is a surgical implant for a therapeutic purpose, not a diagnostic test performed in vitro (outside the body) on biological samples.
  • Device Description: The device is a dental implant system made of titanium, designed for surgical implantation.
  • Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting specific analytes, or providing diagnostic information about a patient's health status.

The device is a medical device, specifically a dental implant, used for treatment and restoration of function.

N/A

Intended Use / Indications for Use

The A Plus Internal Fixture System is intended to be placed in the upper or lower jaw to support prosthetic devices, such as artificial teeth, and to restore a patient's chewing function. This may be accomplished using either a two stage surgical procedure or a single stage surgical procedure. It is intended for delayed loading.

Product codes

DZE, NHA

Device Description

The A Plus internal fixtures are made with Grade 4 titanium. The systems consist of one-stage and two-stage root form dental implants, associated with abutment systems, which provide the dentist with screw and cement retained restoration options.

The devices covered by this submission are A Plus internal fixture, screw, abutment and some accessories. The diameters of A Plus internal fixtures are 3.4 mm, 3.8 mm, 4.3 mm, 4.8 mm, and 5.3 mm, and the lengths are 8 mm, 10 mm, 12 mm, and 14 mm.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

upper or lower jaw

Indicated Patient Age Range

Not Found

Intended User / Care Setting

dentist

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Non-clinical Testing:

  • Sterilization Test (leveraged from own K070562 predicate)
  • A Shelf Life Test (leveraged from own K052369 predicate)
  • Biocompatibility testing (leveraged from own K052369 predicate):
    • Cytotoxicity Test
    • Intracutaneous Reactivity Test
    • Maximization Sensitization Test
    • Systemic Injection Test (Intravenous Injection)
    • Pyrogen Test
    • 90-Day Bone Implantation Study
  • Performance testing: Fatigue test. The fatigue testing has been conducted on the proposed device in accordance with ISO 14801. Test results comply with ISO14801. It approves the proposed device is substantially equivalent to the predicate devices.
  • RBM surface coating: The cleaning validation test and SEM/EDX analysis have been conducted on the proposed device to verify that any particles or chemicals used to remove particles have been washed from the surface.

Key results: All the test results demonstrate that A Plus Internal Fixture System meets the requirements of its pre-defined acceptance criteria and intended use. The results of non-clinical testing indicated the device was found to be substantially equivalent to the predicate devices.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K070562, K052369

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 872.3640 Endosseous dental implant.

(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.

0

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus, which is a symbol often associated with healthcare. The caduceus is depicted with three intertwined snakes and a pair of wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the caduceus.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

June 7, 2016

T-Plus Implant Tech. Co., Ltd. Dana Cheng Quality Assurance No.41, Wuquan 6th Rd., Wugu Dist., New Taipei City, 24889 TAIWAN

Re: K152786

Trade/Device Name: A Plus Internal Fixture System Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: Class II Product Code: DZE, NHA Dated: May 9, 2016 Received: May 10, 2016

Dear Dana Cheng:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act

1

or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Susan Runno DDS, MA

Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

T-Plus Implant Tech. Co., Ltd. 510(k) Notification

A Plus Internal Fixture System

Indications for Use

510(k) Number (if known): K152786 A Plus Internal Fixture System Device Name:

Indications for Use:

The A Plus Internal Fixture System is intended to be placed in the upper or lower jaw to support prosthetic devices, such as artificial teeth, and to restore a patient's chewing function. This may be accomplished using either a two stage surgical procedure or a single stage surgical procedure. It is intended for delayed loading.

Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

AND/OR

Concurrence of CDRH, Office of Device Evaluation (ODE)

Page 1 of 1

3

A Plus Internal Fixture System

510(k) Summary

5.1Type of Submission:Traditional
5.2Date of summary:06/06/2016
5.3Submitter:T-Plus Implant Tech. Co., Ltd.
Address:No.41, Wuquan 6th Rd., Wugu Dist., New
Taipei City 24889, Taiwan (R.O.C)
Phone:+886-2-22981950
Fax:+886-2-22984353
Contact:Dana Cheng(tplus.dana@gmail.com)

5.4 Identification of the Device:

Proprietary/Trade name:A Plus Internal Fixture System
Classification Name:Endosseous Dental Implant
Device Classification:Class II
Review Panel:Dental
Regulation Number:872.3640
Primary Product Code:DZE
Subsequent Product Code:NHA

5.5 Primary Predicate Device (K070562)

Predicate Device Name:EZ Plus Implant System
Manufacturer:Mega'Gen Company, Limited
Device Classification:Class II
Review Panel:Dental
Regulation Number:872.3640
Primary Product Code:DZE
Subsequent Product Code:NHA

4

A Plus Internal Fixture System

5.6 Reference Predicate Device (K052369)

Predicate Device Name:ExFeel Dental Implant System
Manufacturer:Mega'Gen Company, Limited
Device Classification:Class II
Review Panel:Dental
Regulation Number:872.3640
Product Code:DZE

5.7 Intended Use and Indications for Use of the subject device

The A Plus Internal Fixture System is intended to be placed in the upper or lower jaw to support prosthetic devices, such as artificial teeth, and to restore a patient's chewing function. This may be accomplished using either a two stage surgical procedure or a single stage surgical procedure. It is intended for delayed loading.

5.8 Device Description

The A Plus internal fixtures are made with Grade 4 titanium. The systems consist of one-stage and two-stage root form dental implants, associated with abutment systems, which provide the dentist with screw and cement retained restoration options.

The devices covered by this submission are A Plus internal fixture, screw, abutment and some accessories. The diameters of A Plus internal fixtures are 3.4 mm, 3.8 mm, 4.3 mm, 4.8 mm, and 5.3 mm, and the lengths are 8 mm, 10 mm, 12 mm, and 14 mm.

5

Specification (mm)Angulation
ComponentDLcuff HPost Hrange
A Plus Cover Screw3.15, 3.356.60, 7.10N/AN/AN/A
A Plus Healing Screw4.0, 5.0, 6.03.0, 4.0, 5.0,
6.0, 7.0N/AN/AN/A
A Plus Abutment Screw2.310.8N/AN/AN/A
A Plus EZ Post Abutment4.0, 5.0, 6.0N/A1.0, 2.0, 3.0,
4.0, 5.05.2N/A
A Plus Angled Abutment4.0, 5.0, 6.0N/A2.0, 3.0, 4.0,
5.0N/A15°, 25°

The range of diameters and angulations for each screw model and abutment model are provided as below:

5.9 Non-clinical Testing

A series of tests were performed to assess the proposed device is substantially equivalent to the predicate devices. All the test results demonstrate that A Plus Internal Fixture System meets the requirements of its pre-defined acceptance criteria and intended use.

  • Sterilization Test (leveraged from own K070562 predicate)

  • A Shelf Life Test (leveraged from own K052369 predicate)
  • Biocompatibility testing (leveraged from own K052369 predicate):

    • . Cytotoxicity Test
    • . Intracutaneous Reactivity Test
    • . Maximization Sensitization Test
    • Systemic Injection Test (Intravenous Injection) .
    • . Pyrogen Test
    • . 90-Day Bone Implantation Study

6

  • Performance testing:

    • Fatigue test

A fatigue test is required to evaluate the stability of implant system in oral cavity. The fatigue testing has been conducted on the proposed device in accordance with ISO 14801. Test results comply with ISO14801. It approves the proposed device is substantially equivalent to the predicate devices.

  • . RBM surface coating
    A Plus Internal Fixtures and the predicate devices undergo an implant surface treatment of Resorbable Blast Media (RBM). The cleaning validation test and SEM/EDX analysis have been conducted on the proposed device to verify that any particles or chemicals used to remove particles have been washed from the surface.

5.10 Clinical Testing

No additional clinical testing was necessary for a determination of substantial equivalence. The results of non-clinical testing indicated the device was found to be substantially equivalent to the predicate devices.

5.11 Substantial Equivalence Determination

The A Plus Internal Fixture System submitted in this 510(k) file is substantially equivalent in intended use, main materials, implant surface treatment, angulation range, safety and performance claims to the cleared EZ Plus Implant System (K070562) and ExFeel Dental Implant System (K052369). Differences of proposed device and predicate devices do not raise new issues of substantial equivalence.

7

A Plus Internal Fixture System

Proposed devicePredicate device
ItemA Plus Internal
Fixture SystemEZ Plus Implant
SystemExFeel Dental
Implant System
ManufacturerT-Plus Implant Tech.
Co., Ltd.MegaGen Co., Ltd.MegaGen Co., Ltd.
510(k) NumberK152786K070562K052369
ClassificationClass IIClass IIClass II
Intended UseThe A Plus Internal
Fixture System is
intended to be placed
in the upper or lower
jaw to support
prosthetic devices,
such as artificial
teeth, and to restore a
patient's chewing
function. This may
be accomplished
using either a two
stage surgical
procedure or a single
stage surgical
procedure. It is
intended for delayed
loading.The EZ Plus Implant
System is intended to
be surgically placed in
the upper or lower jaw
to support prosthetic
devices, such as
artificial teeth, and to
restore a patient's
chewing function. This
may be accomplished
using either a two
stage or a single stage
surgical procedure.
Large angle abutments
(e.g. 25°) on small
diameter implants of
the EZ Plus internal
connection system are
intended for the
anterior region of the
mouth and not
intended for use in the
posterior region of the
mouth due to limited
strength of the implant.The ExFeel Dental
Implant Systems are
intended to be placed
in the upper or lower
jaw to support
prosthetic devices,
such as artificial
teeth, and to restore a
patient's chewing
function This may be
accomplished using
either a two stage
surgical procedure or
a single stage surgical
procedure.
Proposed devicePredicate device
ItemA Plus Internal
Fixture SystemEZ Plus Implant
SystemExFeel Dental
Implant System
MaterialC.P Titanium
and Titanium Alloy
Implantsurface
treatmentRBMRBMRBM
Implant toabutment
connectionInternal Hex
ConnectionInternal Trip
ConnectionInternal and External
Hex
Implant SterileYesYesYes
SterilizationGamma IrradiationGamma IrradiationGamma Irradiation
Implant
size (mm)Diameters3.4, 3.8, 4.3, 4.8, 5.33.3, 4.0, 5.03.75 - 5.5
Lengths8.0, 10.0, 12.0, 14.08.0, 10.0, 11.0, 13.0,
15.0, 18.07.0 - 18.0

8

Implant

Abutment model

Proposed devicePredicate device
ItemA Plus Internal
Fixture SystemEZ Plus Implant
SystemExFeel Dental
Implant System
MaterialC.P Titanium and
Titanium AlloyC.P Titanium and
Titanium AlloyC.P Titanium and
Titanium Alloy
EZ Post Abutment
Diameters (mm)4.0, 5.0, 6.04.0, 5.0, 6.04.0, 5.0, 6.0
Cuff H1.0, 2.0, 3.0, 4.0, 5.01.0, 2.0, 3.0, 4.0, 5.0-
Post H5.25.2-
Angled Abutment
Diameters (mm)4.0, 5.0, 6.04.0, 5.0, 6.04.0, 5.0, 6.0
Cuff2.0, 3.0, 4.0, 5.02.0, 3.0, 4.0, 5.02.0, 4.0
Angulation range15°, 25°15°, 25°15°, 25°
SterilizationNoneNoneNone

9

Similarity and differences 5.12

The differences between the proposed device and the predicate devices are the design of implant to abutment connection and accessory components. The proposed device was tested, and the results complied with the pre-defined success criteria. Therefore, the differences of proposed device and predicate devices did not raise any problems of substantial equivalence. The proposed device is substantially equivalent to the predicate devices in intended use, design, safety and performance claims.

5.13 Conclusion

After analyzing bench tests, device description and intended use/indications for use, it can be concluded that A Plus Internal Fixture System is substantial equivalence to the predicate devices.